Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $351,410 | $442,735 | $410,596 | $413,753 |
| % Growth | -20.6% | 7.8% | -0.8% | – |
| Cost of Goods Sold | $7,552 | $6,148 | $1,418 | $70,405 |
| Gross Profit | $343,858 | $436,587 | $409,178 | $343,348 |
| % Margin | 97.9% | 98.6% | 99.7% | 83% |
| R&D Expenses | $111,421 | $116,085 | $44,265 | $70,405 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $115,994 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $139,313 | $1,265,932 | -$1,418 | $40,684 |
| Operating Expenses | $250,734 | $1,382,017 | $158,841 | $111,089 |
| Operating Income | $93,124 | -$945,430 | $250,337 | $232,259 |
| % Margin | 26.5% | -213.5% | 61% | 56.1% |
| Other Income/Exp. Net | -$27,926 | -$2,639 | $2,085 | -$31,602 |
| Pre-Tax Income | $65,198 | -$948,069 | $252,422 | $200,657 |
| Tax Expense | $64,318 | $83,490 | $77,357 | -$327,791 |
| Net Income | $880 | -$1,002,239 | $175,065 | $528,448 |
| % Margin | 0.3% | -226.4% | 42.6% | 127.7% |
| EPS | 0.006 | -6.45 | 1.13 | 3.26 |
| % Growth | 100.1% | -670.8% | -65.3% | – |
| EPS Diluted | 0.006 | -6.45 | 0.96 | 3.21 |
| Weighted Avg Shares Out | 159,083 | 155,435 | 154,366 | 162,245 |
| Weighted Avg Shares Out Dil | 160,084 | 155,435 | 186,312 | 164,418 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,468 | $18,971 | $9,501 | $726 |
| Interest Expense | $33,034 | $21,629 | $7,598 | $31,150 |
| Depreciation & Amortization | $2,011 | $1,575 | $1,418 | $1,523 |
| EBITDA | $97,728 | $197,411 | $261,438 | $233,738 |
| % Margin | 27.8% | 44.6% | 63.7% | 56.5% |